Arvinas (ARVN) EBIT Growth (1y) (2018 - 2026)
Arvinas (ARVN) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
1.27% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-347.04% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-189.36% |
| Date | Value |
|---|
| Mar 31, 2026 |
-189.36% |
| Dec 31, 2025 |
-28.18% |
| Sep 30, 2025 |
27.36% |
| Jun 30, 2025 |
-47.42% |
| Mar 31, 2025 |
185.71% |
| Dec 31, 2024 |
64.79% |
| Sep 30, 2024 |
18.40% |
| Jun 30, 2024 |
34.99% |
| Mar 31, 2024 |
5.02% |
| Dec 31, 2023 |
-118.65% |
| Sep 30, 2023 |
-14.93% |
| Jun 30, 2023 |
-13.37% |
| Mar 31, 2023 |
-51.99% |
| Dec 31, 2022 |
-59.16% |
| Sep 30, 2022 |
-35.94% |
| Jun 30, 2022 |
-26.78% |
| Mar 31, 2022 |
-38.37% |
| Dec 31, 2021 |
-21.31% |
| Sep 30, 2021 |
-48.99% |
| Jun 30, 2021 |
-95.97% |
